skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Refinado por: assunto: Biological And Medical Sciences remover assunto: Tumors remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients
Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients

Desar, Ingrid M.E. ; Jacobs, J. (Hans) F.M. ; Hulsbergen‐vandeKaa, Christina A. ; Oyen, Wim J.G. ; Mulders, Peter F.A. ; van der Graaf, Winette T.A. ; Adema, Gosse J. ; van Herpen, Carla M.L. ; de Vries, I. (Jolanda) J.M.

International journal of cancer, 2011-07, Vol.129 (2), p.507-512 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
12
Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia
Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Thomas, Deborah A. ; Faderl, Stefan ; O'Brien, Susan ; Bueso‐Ramos, Carlos ; Cortes, Jorge ; Garcia‐Manero, Guillermo ; Giles, Francis J. ; Verstovsek, Srdan ; Wierda, William G. ; Pierce, Sherry A. ; Shan, Jianqin ; Brandt, Mark ; Hagemeister, Fredrick B. ; Keating, Michael J. ; Cabanillas, Fernando ; Kantarjian, Hagop

Cancer, 2006-04, Vol.106 (7), p.1569-1580 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
13
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes

ALFARO, C ; SUAREZ, N ; GRANDE-PULIDO, E ; MELERO, I ; PEREZ-GRACIA, J. L ; GONZALEZ, A ; SOLANO, S ; ERRO, L ; DUBROT, J ; PALAZON, A ; HERVAS-STUBBS, S ; GURPIDE, A ; LOPEZ-PICAZO, J. M

British journal of cancer, 2009-04, Vol.100 (7), p.1111-1119 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
14
Immune modulation for cancer therapy
Immune modulation for cancer therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune modulation for cancer therapy

NAIDOO, J ; PAGE, D. B ; WOLCHOK, J. D

British journal of cancer, 2014-12, Vol.111 (12), p.2214-2219 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
15
Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits
Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits

Yang, C. H. ; Gonzalez-Angulo, A. M. ; Reuben, J. M. ; Booser, D. J. ; Pusztai, L. ; Krishnamurthy, S. ; Esseltine, D. ; Stec, J. ; Broglio, K. R. ; Islam, R. ; Hortobagyi, G. N. ; Cristofanilli, M.

Annals of oncology, 2006-05, Vol.17 (5), p.813-817 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
16
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers

STERN, M ; PASSWEG, J. R ; TICHELLI, A ; SCHWABE, D ; KOEHL, U ; MEYER-MONARD, S ; ESSER, R ; TONN, T ; SOERENSEN, J ; PAULUSSEN, M ; GRATWOHL, A ; KLINGEBIEL, T ; BADER, P

Bone marrow transplantation (Basingstoke), 2013-03, Vol.48 (3), p.433-438 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
17
Radiation Enhances Regulatory T Cell Representation
Radiation Enhances Regulatory T Cell Representation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radiation Enhances Regulatory T Cell Representation

Kachikwu, Evelyn L., M.D ; Iwamoto, Keisuke S., Ph.D ; Liao, Yu-Pei, Ph.D ; DeMarco, John J., Ph.D ; Agazaryan, Nzhde, Ph.D ; Economou, James S., M.D., Ph.D ; McBride, William H., D.Sc ; Schaue, Dörthe, Ph.D

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.1128-1135 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
18
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

Amato, Robert J. ; Jac, Jaroslaw ; Giessinger, Sarah ; Saxena, Somyata ; Willis, James P.

Cancer, 2009-06, Vol.115 (11), p.2438-2446 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
19
anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells

Galustian, Christine ; Meyer, Brendan ; Labarthe, Marie-Christine ; Dredge, Keith ; Klaschka, Deborah ; Henry, Jake ; Todryk, Stephen ; Chen, Roger ; Muller, George ; Stirling, David ; Schafer, Peter ; Bartlett, J. Blake ; Dalgleish, Angus G

Cancer Immunology, Immunotherapy, 2009-07, Vol.58 (7), p.1033-1045 [Periódico revisado por pares]

Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag

Texto completo disponível

Citações Citado por
20
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)

AMADORI, Sergio ; SUCIU, Stefan ; THOMAS, Xavier ; LATAGLIATA, Roberto ; HALKES, Constantijn J. M ; FALZETTI, Franca ; MAGRO, Domenico ; GUIMARAES, José E ; BERNEMAN, Zwi ; SPECCHIA, Giorgina ; KARRASCH, Matthias ; FAZI, Paola ; STASI, Roberto ; VIGNETTI, Marco ; WILLEMZE, Roel ; DE WITTE, Theo ; MARIE, Jean-Pierre ; SALIH, Helmut R ; SELLESLAG, Dominik ; MUUS, Petra ; DE FABRITIIS, Paolo ; VENDITTI, Adriano ; HO, Anthony D ; LÜBBERT, Michael

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4424-4430 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2003  (3)
  2. 2003Até2004  (7)
  3. 2005Até2006  (9)
  4. 2007Até2009  (45)
  5. Após 2009  (60)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.